NASDAQ:CVET - Covetrus Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $25.67
  • Forecasted Upside: -5.18 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$27.07
▲ +0.48 (1.81%)
1 month | 3 months | 12 months
Get New Covetrus Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CVET and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVET

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$25.67
▼ -5.18% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Covetrus in the last 3 months. The average price target is $25.67, with a high forecast of $31.00 and a low forecast of $20.00. The average price target represents a -5.18% upside from the last price of $27.07.
Buy
The current consensus among 3 investment analysts is to buy stock in Covetrus. This rating has held steady since August 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/7/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/4/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
8/30/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/28/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/11/2020Credit Suisse GroupBoost Price TargetNeutral$17.00 ➝ $20.00Medium
i
Rating by Erin Wright at Credit Suisse Group AG
10/21/2020Raymond JamesBoost Price TargetOutperform$26.00 ➝ $31.00High
i
9/16/2020Stifel NicolausUpgradeHold ➝ Buy$23.00 ➝ $26.00High
i
9/10/2020Raymond JamesReiterated RatingBuyMedium
i
8/12/2020Credit Suisse GroupBoost Price TargetNeutral$12.00 ➝ $14.00High
i
Rating by Erin Wright at Credit Suisse Group AG
8/12/2020Stifel NicolausBoost Price TargetHold$20.00 ➝ $23.00High
i
8/12/2020Raymond JamesBoost Price TargetOutperform$14.00 ➝ $26.00High
i
7/30/2020Stifel NicolausBoost Price TargetHold$11.00 ➝ $20.00High
i
5/22/2020Credit Suisse GroupBoost Price TargetNeutral$10.00 ➝ $12.00Low
i
Rating by Erin Wright at Credit Suisse Group AG
4/23/2020Credit Suisse GroupLower Price TargetNeutral$13.00 ➝ $10.00High
i
3/4/2020Credit Suisse GroupBoost Price TargetNeutral$11.00 ➝ $13.00High
i
10/17/2019Credit Suisse GroupLower Price TargetNeutral$15.00 ➝ $11.00High
i
Rating by Erin Wright at Credit Suisse Group AG
9/9/2019The Goldman Sachs GroupInitiated CoverageSell$11.00High
i
8/16/2019Credit Suisse GroupSet Price TargetHold$15.00Low
i
Rating by Erin Wright at Credit Suisse Group AG
8/15/2019Raymond JamesLower Price TargetOutperform$45.00 ➝ $21.00High
i
8/14/2019Stifel NicolausLower Price TargetHold$30.00 ➝ $18.00High
i
5/23/2019GuggenheimInitiated CoverageNeutralHigh
i
5/22/2019Stifel NicolausInitiated CoverageHold ➝ Hold$30.00High
i
5/10/2019Cleveland ResearchInitiated CoverageHoldHigh
i
Rating by Rob Eich at Cleveland Research
4/4/2019Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$35.00Low
i
3/20/2019SVB LeerinkReiterated RatingOutperformHigh
i
Rating by D. Larsen at SVB Leerink LLC
2/27/2019Raymond JamesInitiated CoverageOutperform ➝ Outperform$45.00High
i
2/12/2019William BlairInitiated CoverageOutperform ➝ OutperformN/A
i
Rating by J. Kreger at William Blair
(Data available from 11/28/2015 forward)
Covetrus logo
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins and supplements to wholesale and retail customers. The company also offers value-added practice solutions that include financial services, equipment repair, inventory management, and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as e-commerce, shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company, formerly known as HS Spinco, Inc., was incorporated in 2018 and is headquartered in Portland, Maine.
Read More

Today's Range

Now: $27.07
$26.67
$27.27

50 Day Range

MA: $26.25
$24.69
$28.29

52 Week Range

Now: $27.07
$4.05
$30.13

Volume

341,034 shs

Average Volume

1,387,045 shs

Market Capitalization

$3.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.48